Trial intelligence / Profile preview

Electroacupuncture for Generalized Anxiety Disorder

NCT07392645Recruiting

Start
Mar 2026
Primary completion
Oct 2027
Countries
1
01

Overview

Randomised, single-blind trial in generalized anxiety disorder (GAD) (3 arms). Primary endpoint: Effective rate of Hamilton Anxiety Rating Scale score reduction at 4 weeks. Started Mar 2026; status: recruiting.

02

Conditions

generalized anxiety disorder (GAD)

Beyond the preview

Go deeper on NCT07392645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07392645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call